SCHEMBL5590794

SCHEMBL5590794

NC1(S)C=CN([C@H]2CC(O)[C@@H](CO)O2)C(=O)O1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ ADRB1 P08588 1/20 0.44
▸ DNMT1 P26358 1/20 0.44
▸ TK1 P04183 3/20 0.41
▸ ALOX12 P18054 1/20 0.39
▸ ADRA1A P35348 1/20 0.39
▸ TK2 O00142 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ BLM P54132 1/20 0.38
▸ PMP22 Q01453 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ PIM1 P11309 1/20 0.36
▸ CSNK2A2 P19784 1/20 0.36
▸ CSNK2B P67870 1/20 0.36
▸ CSNK2A1 P68400 1/20 0.36
▸ CSNK2A3 Q8NEV1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5193538 0.78 LMNA (0.46) LMNASMN1; SMN2ADRB1DNMT1TK1
SCHEMBL27041390 0.77 LMNA (0.46) LMNASMN1; SMN2ADRB1DNMT1TK1
SCHEMBL22978936 0.75 LMNA (0.44) LMNASMN1; SMN2ADRB1DNMT1TK1
SCHEMBL9353684 0.75 LMNA (0.44) LMNASMN1; SMN2ADRB1DNMT1TK1
SCHEMBL789521 0.75 LMNA (0.44) LMNASMN1; SMN2ADRB1DNMT1TK1
SCHEMBL29230391 0.74 LMNA (0.43) LMNASMN1; SMN2ADRB1DNMT1TK1
SCHEMBL10898979 0.73 LMNA (0.42) LMNASMN1; SMN2ADRB1DNMT1TK1
SCHEMBL16378861 0.73 LMNA (0.49) LMNASMN1; SMN2ADRB1DNMT1TK1
SCHEMBL29388908 0.73 LMNA (0.49) LMNASMN1; SMN2ADRB1DNMT1TK1
SCHEMBL29803038 0.72 LMNA (0.42) LMNASMN1; SMN2ADRB1DNMT1TK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113631563-A Compositions and methods for treating, preventing or reversing age-related inflammation and disease 布朗大学 2021-11-09 — — CN disclosed
EP-1749041-A2 CELLULOSE AND ACRYLIC BASED POLYMERS AND THE USE THEREOF FOR THE TREATMENT OF INFECTIOUS DISEASES Nova Flux Biosciences, Inc. (US) 2007-02-07 — — EP disclosed
WO-2005111112-A2 CELLULOSE AND ACRYLIC BASED POLYMERS AND THE USE THEREOF FOR THE TREATMENT OF INFECTIOUS DISEASES NOVA FLUX BIOSCIENCES, INC. (US) 2005-11-24 — — WO disclosed
Send feedback